|
|
|
|
|
1.
1731 Accesses
|
Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term
Rachel C Jankowitz, Adam M Brufsky Breast Cancer Research 2012, 14:308 (30 April 2012)
Abstract | Full text | PDF | PubMed
|
|
|
2.
1439 Accesses
|
Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer
Luigi Strizzi, Katharine M Hardy, Naira V Margaryan, David W Hillman, Elisabeth A Seftor, Beiyun Chen, Xochiquetzal J Geiger, E Thompson, Wilma L Lingle, Cathy A Andorfer, Edith A Perez, Mary JC Hendrix Breast Cancer Research 2012, 14:R75 (11 May 2012)
Abstract | Provisional PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
The embryonic morphogen Nodal is associated with advanced stage invasive human breast cancer, and may have a role as both a prognostic biomarker and a therapeutic target.
|
|
|
3.
1427 Accesses
|
Biomarkers characterization of circulating tumour cells in breast cancer patients
Rosa Nadal, Ana Fernandez, Pedro Sanchez-Rovira, Marta Salido, María Rodríguez, José García-Puche, Marta Macià, Josep Corominas, Miguel Delgado-Rodriguez, Lucas Gonzalez, Joan Albanell, Mónica Fernández, Francesc Solé, José Lorente, María Serrano Breast Cancer Research 2012, 14:R71 (3 May 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
4.
1134 Accesses
|
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
Grazia Arpino, Valerie J Bardou, Gary M Clark, Richard M Elledge Breast Cancer Res 2004, 6:R149-R156 (17 February 2004)
Abstract | Full text | PDF | Cited on BioMed Central
|
|
|
5.
1051 Accesses
|
Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer
Rachel L Dusek, Jamie L Bascom, Hannes Vogel, Sylvain Baron, Alexander D Borowsky, Mina J Bissell, Laura D Attardi Breast Cancer Research 2012, 14:R65 (20 April 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
The protein Perp, associated with desmosomes - the glue that sticks cells together - is involved in suppressing breast cancer and provides a potential new target for future treatment.
|
|
|
6.
1028 Accesses
|
Mouse models of breast cancer metastasis
Anna Fantozzi, Gerhard Christofori Breast Cancer Research 2006, 8:212 (26 July 2006)
Abstract | Full text | PDF | PubMed
|
|
|
7.
976 Accesses
|
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos, Jan Lubinski, Leonardo Salmena, Henry T Lynch, Charmaine Kim-Sing, William D Foulkes, Parviz Ghadirian, Susan L Neuhausen, Rochelle Demsky, Nadine Tung, Peter Ainsworth, Leigha Senter, Andrea Eisen, Charis Eng, Christian Singer, Ophira Ginsburg, Joanne Blum, Tomasz Huzarski, Aletta Poll, Ping Sun, Steven A Narod, the Hereditary Breast Cancer Clinical Study Group Breast Cancer Research 2012, 14:R42 (9 March 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Breastfeeding is protective against BRCA1- but not BRCA2-associated breast cancer, suggesting they have different biological pathways for carcinogenesis, and mutation carriers should be advised of the potential benefit of breastfeeding.
|
|
|
8.
940 Accesses
|
Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study
Song Yao, Gary Zirpoli, Dana H Bovbjerg, Lina Jandorf, Chi Chen Hong, Hua Zhao, Lara E Sucheston, Li Tang, Michelle Roberts, Gregory Ciupak, Warren Davis, Helena Hwang, Candace S Johnson, Donald L Trump, Susan E McCann, Foluso Ademuyiwa, Karen S Pawlish, Elisa V Bandera, Christine B Ambrosone Breast Cancer Research 2012, 14:R58 (4 April 2012)
Abstract | Full text | PDF | PubMed |
|
Editor’s summary
Genetic variations in the vitamin D receptor and CYP24A1, an enzyme responsible for deactivating vitamin D, are associated with an increase in breast cancer risk for African American women.
|
|
|
9.
865 Accesses
|
Breast asymmetry and predisposition to breast cancer
Diane Scutt, Gillian A Lancaster, John T Manning Breast Cancer Research 2006, 8:R14 (20 March 2006)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Breast asymmetry could be a predictor of breast cancer, with the relative risk of developing cancer rising with increases in breast volume asymmetry.
|
|
|
10.
816 Accesses
|
Estrogen-related receptor alpha: an orphan finds a family
Aleksandra M Ochnik, Douglas Yee Breast Cancer Research 2012, 14:309 (10 May 2012)
Abstract | Full text | PDF | PubMed
|
|
|
11.
799 Accesses
|
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He, Charles M Perou Breast Cancer Research 2010, 12:R68 (2 September 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
12.
799 Accesses
|
CENP-A, an essential centromere protein, is a prognostic marker for relapse
in estrogen receptor-positive breast cancer
Susan L McGovern, Yuan Qi, Lajos Pusztai, William F Symmans, Thomas A Buchholz Breast Cancer Research 2012, 14:R72 (4 May 2012)
Abstract | Provisional PDF
| PubMed
|
Editor’s summary
The essential centromere protein, CENP-A, is a strong prognostic marker for distant relapse in estrogen-receptor positive breast cancer not treated with systemic therapy, and may contribute to disease progression.
|
|
|
13.
734 Accesses
|
Breast cancer cell lines: friend or foe?
Sarah E Burdall, Andrew M Hanby, Mark RJ Lansdown, Valerie Speirs Breast Cancer Res 2003, 5:89-95 (3 February 2003)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
14.
731 Accesses
|
Next-generation sequencing
Jorge S Reis-Filho Breast Cancer Research 2009, 11(Suppl 3):S12 (18 December 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
15.
722 Accesses
|
Current approaches to the management of Her2-negative metastatic breast cancer
Keerthi Gogineni, Angela DeMichele Breast Cancer Research 2012, 14:205 (19 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
16.
722 Accesses
|
Targeting triple-negative breast cancer cells with the HDAC inhibitor Panobinostat
Chandra R Tate, Lyndsay V Rhodes, H CHRIS Segar, Jennifer L Driver, F NELL Pounder, Matthew E Burow, Bridgette M Collins-Burow Breast Cancer Research 2012, 14:R79 (21 May 2012)
Abstract | Provisional PDF
| PubMed
|
Editor’s summary
Panobinostat is able to selectively target triple negative breast cancer (TNBC) cells by inducing hyperacetylation and cell cycle arrest at G2/M; partially reversing the morphological changes characteristic of breast cancer cells.
|
|
|
17.
719 Accesses
|
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
Martin A Rivas, Leandro Venturutti, Yi-Wen Huang, Roxana Schillaci, Tim Huang, Patricia V Elizalde Breast Cancer Research 2012, 14:R77 (14 May 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
18.
693 Accesses
|
CIP2A is a target of bortezomib in human triple negative breast cancer cells
Ling-Ming Tseng, Chun-Yu Liu, Kung-Chi Chang, Pei-Yi Chu, Chung-Wai Shiau, Kuen-Feng Chen Breast Cancer Research 2012, 14:R68 (26 April 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
19.
658 Accesses
|
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan, Hiromitsu Kishimoto, Robyn K Fuchs, Sanjana Mehrotra, Poornima Bhat-Nakshatri, Charles H Turner, Robert Goulet, Sunil Badve, Harikrishna Nakshatri Breast Cancer Research 2006, 8:R59 (24 October 2006)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
20.
643 Accesses
|
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M Fillmore, Charlotte Kuperwasser Breast Cancer Research 2008, 10:R25 (26 March 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
21.
635 Accesses
|
The p53 pathway in breast cancer
Milena Gasco, Shukri Shami, Tim Crook Breast Cancer Res 2002, 4:70-76 (12 February 2002)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
22.
635 Accesses
|
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study
Rebecca Ritte, Annekatrin Lukanova, Franco Berrino, Laure Dossus, Anne Tjønneland, Anja Olsen, Thure Overvad, Kim Overvad, Françoise Clavel-Chapelon, Agnès Fournier, Guy Fagherazzi, Sabine Rohrmann, Birgit Teucher, Heiner Boeing, Krasimira Aleksandrova, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Domenico Palli, Sabina Sieri, Salvatore Panico, Rosario Tumino, Paolo Vineis, José Quirós, Genevieve Buckland, Maria-José Sánchez, Pilar Amiano, María-Dolores Chirlaque, Eva Ardanaz, Malin Sund, Per Lenner, Bas Bueno-de-Mesquita, Carla H van Gils, Petra HM Peeters et al.
Breast Cancer Research 2012, 14:R76 (14 May 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
23.
624 Accesses
|
Coffee consumption modifies risk of estrogen-receptor negative breast cancer
Jingmei Li, Petra Seibold, Jenny Chang-Claude, Dieter Flesch-Janys, Jianjun Liu, Kamila Czene, Keith Humphreys, Per Hall Breast Cancer Research 2011, 13:R49 (14 May 2011)
Abstract | Full text | PDF | PubMed | F1000 Biology
|
Editor’s summary
A Swedish study finds that a high daily intake of coffee is associated with a statistically significant decrease in estrogen receptor-negative breast cancer among postmenopausal women.
|
|
|
24.
607 Accesses
|
Classical peer review: an empty gun
Richard Smith Breast Cancer Research 2010, 12(Suppl 4):S13 (20 December 2010)
Full text | PDF | PubMed | Cited on BioMed Central |
|
|
|
25.
586 Accesses
|
Breast cancer tumor growth estimated through mammography screening data
Harald Weedon-Fekjær, Bo H Lindqvist, Lars J Vatten, Odd O Aalen, Steinar Tretli Breast Cancer Research 2008, 10:R41 (8 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
A new model which can estimate the growth rate of breast cancer, as well as the proportion of tumors detected at screening, shows slower growth rates with increasing age.
|